Assuntos
Infecções por HIV/urina , Porfobilinogênio/urina , Porfiria Aguda Intermitente/urina , Quadriplegia/urina , Urina/química , Adulto , Terapia Antirretroviral de Alta Atividade , Doença Crônica , Diagnóstico Diferencial , Feminino , Infecções por HIV/complicações , Infecções por HIV/tratamento farmacológico , Humanos , Síndrome Inflamatória da Reconstituição Imune/urina , Porfiria Aguda Intermitente/etiologia , Quadriplegia/complicações , Quadriplegia/tratamento farmacológicoAssuntos
Fosfatase Alcalina/sangue , Anemia Hemolítica/diagnóstico , Degeneração Hepatolenticular/diagnóstico , Falência Hepática Aguda/diagnóstico , Adulto , Anemia Hemolítica/sangue , Anemia Hemolítica/complicações , Anemia Hemolítica/terapia , Quelantes/administração & dosagem , Quelantes/uso terapêutico , Cobre/urina , Diagnóstico Diferencial , Feminino , Degeneração Hepatolenticular/sangue , Degeneração Hepatolenticular/complicações , Degeneração Hepatolenticular/terapia , Humanos , Falência Hepática Aguda/sangue , Falência Hepática Aguda/complicações , Falência Hepática Aguda/terapia , Testes de Função Hepática , Penicilamina/administração & dosagem , Penicilamina/uso terapêutico , Plasmaferese , Resultado do Tratamento , Adulto JovemRESUMO
BACKGROUND: It has been known for some time that the antiretroviral drug, efavirenz (EFV), cross-reacts in urine immunoassays for tetrahydrocannabinol (THC). Because published studies investigating this phenomenon are limited, cross-reactivity information for several immunoassays is lacking. Reports of possible false-positive THC results from clinicians conducting workplace testing prompted us to investigate cross-reactivity for assays frequently employed in our own setting. In light of the potentially deleterious consequences of misclassification, information about EFV cross-reactivity should be included in product information to facilitate interpretation of results and assay selection. METHODS: Random urine samples from 30 patients on EFV therapy were analysed for THC metabolites by two near-testing devices (THC One Step Marijuana and Rapid Response(®) Drugs of Abuse Test Strips) and two automated immunoassays (Roche Diagnostics Cannabinoids II and Beckman Coulter SYNCHRON(®) Systems THC2). THC confirmatory testing was performed by gas chromatography-mass spectrometry (GC-MS). RESULTS: GC-MS failed to detect THC metabolites in any of the samples, as did three of the four immunoassays. However, the Rapid Response(®) test strips yielded positive results in 28 out of 30 samples, which could be reversed on re-testing after sample pretreatment with glucuronidase. CONCLUSIONS: Our study supports previous findings that interference is attributable to a glucuronidated EFV metabolite. We postulate that cross-reactivity is influenced by the composition of immunogens used to elicit anti-THC antibodies. Since access to such information is restricted, contributions from scientists in the antibody industry may be enlightening.
Assuntos
Benzoxazinas/urina , Dronabinol/urina , Imunoensaio/métodos , Detecção do Abuso de Substâncias , Alcinos , Ciclopropanos , Cromatografia Gasosa-Espectrometria de Massas , HumanosRESUMO
BACKGROUND: The insecticide dichlorodiphenyltrichloroethane (DDT) has been used for malaria vector control in the northern and eastern parts of the Vhembe District of Limpopo Province, South Africa, since 1945. Bioaccumulation of DDT raises concern because it reportedly affects thyroid function. OBJECTIVE: Our objective was to investigate the association between DDT uptake (as reflected in plasma concentrations) and thyroid homeostasis while considering related factors. METHODS: We compared dietary intake, serum retinol-binding protein (RBP), transthyretin (TTR) and albumin concentrations, and liver and thyroid function between cases with evidence of a body burden of DDT in the circulation (concentration of any DDT isomer ≥ 0.02 µg/g lipid; n = 278) and controls (concentration of all DDT isomers < 0.02 µg/g lipid; n = 40) in a cross-sectional study. Further analyses were performed to assess the relevance of changes in RBP status associated with DDT uptake. RESULTS: RBP concentrations below the reference range were more prevalent in cases (54% vs. 10% in controls; χ² = 27.4; p < 0.001), which could not be explained by nutrient intake. We observed significantly lower thyroid hormone concentrations among cases (p ≤ 0.01). We also observed a significant linear trend for serum concentrations of free thyroxine and free triiodothyronine (p < 0.001) and a significant quadratic trend for serum thyroid-stimulating hormone (p = 0.025) and TTR (p < 0.001) across the control group and case groups with normal and relatively low RBP concentrations. Relatively low RBP concentrations were associated with significantly higher DDT and 1,1-dichloro-2,2-bis(p-chlorophenyl) ethylene (DDE) isomer concentrations and with a higher DDE/DDT ratio (p ≤ 0.01), which signifies long-term exposure. Inadequate intake of vitamin A and zinc were observed in 84% and 58%, respectively, of the total study population. CONCLUSION: RBP concentrations appear to decrease in the presence of long-term DDT uptake, which may have deleterious effects on thyroid function and vitamin A nutritional status. This is of major concern in a population with poor vitamin A and zinc intake.